Table 3 Antimicrobial susceptibility of ST131 Escherichia coli isolates. Data are number of susceptible isolates (percentage)
From: Intestinal colonization due to Escherichia coli ST131: risk factors and prevalence
Antimicrobial | All isolates (n = 28) | Isolates from household members (n = 18) | Isolates from hospital contacts (n = 10) |
|---|---|---|---|
Ampicillin | 6 (21.4) | 6 (33.3) | 0 |
Amoxicillin-clavulanic acid | 9 (31.2) | 9 (50) | 0 |
Piperacillin-tazobactam | 27 (96.4) | 18 (100) | 9 (90) |
Ceftriaxone | 22 (78.5) | 15 (83.3) | 7 (70) |
Ceftazidime | 22 (78.5) | 15 (83.3) | 7 (70) |
Ertapenem | 28 (100) | 18 (100) | 10 (100) |
Ciprofloxacin | 9 (32.1) | 6 (33.3) | 3 (30) |
Gentamicin | 24 (85.7) | 17 (94.4) | 7 (70) |
Tobramycin | 19 (67.8) | 14 (77.8) | 5 (50) |
Amikacin | 28 (100) | 18 (100) | 10 (100) |
Fosfomycin | 28 (100) | 18 (100) | 10 (100) |